ArthaView
Subscribe
Sign in
Home
Notes
Segments
Essentials
Benefactor
Calculators
Q&A
Archive
Latest
Top
A hospital giant’s cure for its own balance-sheet
India’s largest private hospital chain is going public. Investors should check the vital signs before they check in
Jul 26
The cost of buying and selling
Trading, timing and stock-picking all promise an edge. Costs and cycles usually take it back
Jul 24
Three health insurance policies, one important decision
Is an old policy is often worth more than a shiny new one?
Jul 21
How to size a position in a portfolio
In portfolio construction, a formula is worth more than a feeling
Jul 13
Market-Linked Debentures: From Tax Play to Portfolio Tool
Stripped of the tax break that made them famous, market-linked debentures are being sold on a different promise, a cushion against volatility rather…
Jul 10
From safety to swagger
After five years spent bullet-proofing themselves, companies now face pressure to grow
Jul 8
The discipline that did not blink
SIP contributions hit a record in the very month the market fell hardest
Jul 6
Gold's moment arrives - inside a mutual fund wrapper
For the first time, commodity ETFs out-earned equity ETFs in net inflows
Jul 5
The tax-saving fund that ran out of reasons to exist
ELSS recorded its first-ever full-year net outflow. The new tax regime is why
Jul 5
The buyer of last resort
How India's mutual funds absorbed a record foreign exit without the market breaking
Jul 5
1
Boom or bust, India will feel AI differently
A global technology, but its consequences will remain deeply local
Jul 3
2
June 2026
Sai Life Sciences: Following the Molecule
As pharmaceutical companies rethink global supply chains, an Indian CRDMO is quietly positioning itself at the centre of the innovation ecosystem.
Jun 29
9:57
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
